Literature DB >> 26245264

Rituximab-based therapy and long-term control of autoimmune autonomic ganglionopathy.

Arjun Gupta1, Samar Harris2, Steven Vernino3, Harris V Naina4.   

Abstract

We present a patient with autoimmune autonomic ganglionopathy (AAG) who had persistently positive ganglionic nicotinic acetylcholine receptor antibody levels despite immunosuppressive therapy. Rituximab-based therapy for an incidental lymphoma was associated with prolonged symptomatic and serological control of AAG.

Entities:  

Keywords:  Autoimmune autonomic ganglionopathy; Management; Rituximab

Mesh：

Substances：

Year:  2015        PMID： 26245264     DOI： 10.1007/s10286-015-0299-5

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN： 0959-9851            Impact factor:   4.435


  10 in total

1.  Persistent panhypogammaglobulinemia after CHOP-rituximab for HIV-related lymphoma.

Authors:  Steven A Miles; Marie McGratten
Journal:  J Clin Oncol       Date:  2005-01-01       Impact factor: 44.544

2.  Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies.

Authors:  S Vernino; P A Low; R D Fealey; J D Stewart; G Farrugia; V A Lennon
Journal:  N Engl J Med       Date:  2000-09-21       Impact factor: 91.245

3.  Long-term treatment with rituximab of autoimmune autonomic ganglionopathy in a patient with lymphoma.

Authors:  Ryan Hollenbeck; Bonnie K Black; Amanda C Peltier; Italo Biaggioni; David Robertson; Elliott F Winton; Satish R Raj
Journal:  Arch Neurol       Date:  2010-11-08

4.  A Unique Manifestation of Pupillary Fatigue in Autoimmune Autonomic Ganglionopathy.

Authors:  Srikanth Muppidi; Maggie Scribner; Christopher H Gibbons; Beverley Adams-Huet; Elaine B Spaeth; Steven Vernino
Journal:  Arch Neurol       Date:  2012-05

Review 5.  Autoimmune autonomic failure.

Authors:  Srikanth Muppidi; Steven Vernino
Journal:  Handb Clin Neurol       Date:  2013

6.  Antibody titers predict clinical features of autoimmune autonomic ganglionopathy.

Authors:  Christopher H Gibbons; Roy Freeman
Journal:  Auton Neurosci       Date:  2009-01-13       Impact factor: 3.145

7.  Autoimmune autonomic ganglionopathy: treatment by plasma exchanges and rituximab.

Authors:  Richard Imrich; Steven Vernino; Basil A Eldadah; Courtney Holmes; David S Goldstein
Journal:  Clin Auton Res       Date:  2009-04-28       Impact factor: 4.435

8.  Efficacy of immunotherapy in seropositive and seronegative putative autoimmune autonomic ganglionopathy.

Authors:  V Iodice; K Kimpinski; S Vernino; P Sandroni; R D Fealey; P A Low
Journal:  Neurology       Date:  2009-06-09       Impact factor: 9.910

9.  Passive transfer of autoimmune autonomic neuropathy to mice.

Authors:  Steven Vernino; Leonid G Ermilov; Lei Sha; Joseph H Szurszewski; Phillip A Low; Vanda A Lennon
Journal:  J Neurosci       Date:  2004-08-11       Impact factor: 6.167

10.  Combined immunomodulatory therapy in autoimmune autonomic ganglionopathy.

Authors:  Christopher H Gibbons; Steven A Vernino; Roy Freeman
Journal:  Arch Neurol       Date:  2008-02
  10 in total
  4 in total

Review 1.  Postural Orthostatic Tachycardia Syndrome: Prevalence, Pathophysiology, and Management.

Authors:  Adena Zadourian; Taylor A Doherty; Iwona Swiatkiewicz; Pam R Taub
Journal:  Drugs       Date:  2018-07       Impact factor: 9.546

Review 2.  Transcranial Doppler in autonomic testing: standards and clinical applications.

Authors:  Lucy Norcliffe-Kaufmann; Brahyan Galindo-Mendez; Ana-Lucia Garcia-Guarniz; Estibaliz Villarreal-Vitorica; Vera Novak
Journal:  Clin Auton Res       Date:  2017-08-18       Impact factor: 4.435

Review 3.  Autoimmune autonomic neuropathies and ganglionopathies: epidemiology, pathophysiology, and therapeutic advances.

Authors:  Elisabeth P Golden; Steven Vernino
Journal:  Clin Auton Res       Date:  2019-05-15       Impact factor: 4.435

4.  Multiple Myeloma Presenting with Autoimmune Autonomic Ganglionopathy.

Authors:  Yoshiki Nakae; Mizuki Hyuga; Yuta Terada; Wataru Kishimoto; Akiko Fukunaga; Sumie Tabata; Yoshitomo Maesako; Kenichi Komatsu; Osamu Higuchi; Toshinari Nakane; Nobuyoshi Arima
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.